P N Gadgil Jewellers Limited (NSE:PNGJL)

Market Cap	77.52B
Revenue (ttm)	77.40B
Net Income (ttm)	2.52B
Shares Out	135.71M
EPS (ttm)	19.11
PE Ratio	29.90
Forward PE	24.92
Dividend	n/a
Ex-Dividend Date	n/a

Volume	181,142
Average Volume	281,070
Open	571.25
Previous Close	571.20
Day's Range	562.00 - 576.00
52-Week Range	473.80 - 848.00
Beta	n/a
RSI	44.52
Earnings Date	Aug 12, 2025

About Revance Therapeutics

P N Gadgil Jewellers Limited, together with its subsidiaries, engages in the retail sale of gems, diamonds, semi-precious stones, and jewellery products in India and the United States. The company sells traditional, modern, and functional jewellery in gold, silver, platinum, and diamond, including earrings, rings, necklaces, pendants, mangalsutras, bracelets and bangles, and nosepins, as well as naths, chains, and bullions. It also engages in the manufacture and sale of jewellery products. The company sells its products through retail stores an...

• Industry: Luxury Goods
• Sector: Consumer Discretionary
• Founded: 1832
• Employees: 2,100
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PNGJL

Financial Performance

In 2024, P N Gadgil Jewellers's revenue was 76.93 billion, an increase of 25.87% compared to the previous year's 61.12 billion. Earnings were 2.18 billion, an increase of 40.68%.